Skip to main content
Top

Drugs

Issue 18/2022

Content (9 Articles)

Acknowledgement to Referees

  • Acknowledgement to Referees

Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study

Qiang Tong, Yu Du, Ran Cui, Miao Chen, Shiow-Ing Wang, James Cheng-Chung Wei, Sheng-Ming Dai

Futibatinib: First Approval

Yahiya Y. Syed

Dorzagliatin: First Approval

Yahiya Y. Syed

Authors’ Reply to Denning: Comment on: “Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries”

Swathi Pathadka, Vincent K. C. Yan, Chin Fen Neoh, Daoud Al-Badriyeh, David C. M. Kong, Monica A. Slavin, Benjamin J. Cowling, Ivan F. N. Hung, Ian C. K. Wong, Esther W. Chan

Correction: Teprotumumab: A Review in Thyroid Eye Disease

  • Open Access
  • Correction

Tina Nie, Yvette N. Lamb

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images